Verifying…
Home / Drug A–Z / Harvad Ketamine Injection 50 mg/mL_

Harvad Ketamine Injection 50 mg/mL_

NAFDAC Reg. No. A4-101507 · Drug

Registered with NAFDAC. Registration activeAs of 27 October 2026 · synced automatically from official sources.
Product
Harvad Ketamine Injection 50 mg/mL_
NAFDAC number
A4-101507
Active ingredient
Ketamine (Ketamine Hydrochloride)
Strength
50 mg/mL
Form
Injection
Pack size
1 x 10 mL vials
Manufacturer
Not listed
Applicant (holder)
Harvad Pharmaceutical Company Ltd
Approved
27 Aug 2025
Status
Active View on NAFDAC ↗
Registration valid to
26 Aug 2030
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Harvad Ketamine Injection 50 mg/mL_ is on the NAFDAC register with an active registration (A4-101507). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

What Harvad Ketamine Injection 50 mg/mL_ is used for

From the official U.S. FDA label for ketamine (ketamine hydrochloride), the active ingredient registered with NAFDAC.

What it is used for

KETALAR (ketamine hydrochloride) injection is indicated: as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. for the induction of anesthesia prior to the administration of other general anesthetic agents. as a supplement to other anesthetic agents. KETALAR is a general anesthetic indicated: as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation ( 1 ) for the induction of anesthesia prior to the administration of other general anesthetic agents ( 1 ) as a supplement to other anesthetic agents ( 1 ).

Possible side effects

The following clinically significant adverse reactions are described elsewhere in the labeling: Hemodynamic Instability [see Warnings and Precautions ( 5.1 )] Emergence Reactions [see Warnings and Precautions ( 5.2 )] Respiratory Depression [see Warnings and Precautions ( 5.3 )] Pediatric Neurotoxicity [see Warnings and Precautions ( 5.5 )] Drug-Induced Liver Injury [see Warnings and Precautions ( 5.6 )] The following adverse reactions associated with the use of KETALAR were identified in clinical studies or postmarketing reports. …

Do not use if

KETALAR is contraindicated in patients for whom a significant elevation of blood pressure would constitute a serious hazard [see Warnings and Precautions ( 5.1 ) ]. KETALAR is contraindicated in patients with known hypersensitivity to ketamine or to any excipient [see Adverse Reactions ( 6 ) ]. In patients for whom a significant elevation of blood pressure would be a serious hazard ( 4 ). Known hypersensitivity to ketamine or to any excipient ( 4 ).

Warnings

Hemodynamic Instability: Monitor vital signs and cardiac function during KETALAR administration. ( 5.1 ) Emergence Reactions: Postoperative confusional states may occur during the recovery period. Reduce by minimizing verbal, tactile, and visual stimulation of the patient. ( 5.2 ) Risk of Respiratory Depression: May occur with overdosage or too rapid a rate of administration. Maintain adequate oxygenation and ventilation. ( 5.3 ) Risks of KETALAR alone for Procedures of the Pharynx, Larynx, or Bronchial Tree : Pharyngeal and laryngeal reflexes are not suppressed with KETALAR when it is used alone. …

Pregnancy & breastfeeding

8.1 Pregnancy Risk Summary Available data on the use of ketamine in pregnant women mostly describe its use at the time of cesarean section and have not identified a drug-associated risk of adverse maternal or fetal outcomes. The data are limited by retrospective collection, small sample sizes, and a lack of long-term follow-up. …

General information only, not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Harvad Ketamine Injection 50 mg/mL_

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Harvad Ketamine Injection 50 mg/mL_

What is in Harvad Ketamine Injection 50 mg/mL_?

Harvad Ketamine Injection 50 mg/mL_ contains Ketamine (Ketamine Hydrochloride) (50 mg/mL), as injection, according to its NAFDAC registration record.

Is Harvad Ketamine Injection 50 mg/mL_ registered with NAFDAC?

Yes. Harvad Ketamine Injection 50 mg/mL_ is listed on the NAFDAC register under registration number A4-101507, and its registration is active as of 27 October 2026.

Has Harvad Ketamine Injection 50 mg/mL_ been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Harvad Ketamine Injection 50 mg/mL_ in our automatically synced alert list.

How can I check that my pack of Harvad Ketamine Injection 50 mg/mL_ is genuine?

Run a free authenticity scan with the NAFDAC number A4-101507, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Harvad Ketamine Injection 50 mg/mL_ used for?

KETALAR (ketamine hydrochloride) injection is indicated: as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. for the induction of anesthesia prior to the administration of other general anesthetic agents. as a supplement to other anesthetic agents. KETALAR is a general anesthetic indicated: as the sole anesthetic agent for diagnostic (Summarised from the official U.S. FDA label for ketamine (ketamine hydrochloride). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Harvad Ketamine Injection 50 mg/mL_? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.